1. Home
  2. AIMD vs ATPC Comparison

AIMD vs ATPC Comparison

Compare AIMD & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • ATPC
  • Stock Information
  • Founded
  • AIMD 1984
  • ATPC 2016
  • Country
  • AIMD United States
  • ATPC Malaysia
  • Employees
  • AIMD N/A
  • ATPC N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • ATPC Medical/Nursing Services
  • Sector
  • AIMD Health Care
  • ATPC Health Care
  • Exchange
  • AIMD Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • AIMD 5.2M
  • ATPC 5.7M
  • IPO Year
  • AIMD N/A
  • ATPC N/A
  • Fundamental
  • Price
  • AIMD $0.44
  • ATPC $1.45
  • Analyst Decision
  • AIMD
  • ATPC
  • Analyst Count
  • AIMD 0
  • ATPC 0
  • Target Price
  • AIMD N/A
  • ATPC N/A
  • AVG Volume (30 Days)
  • AIMD 255.7K
  • ATPC 257.4K
  • Earning Date
  • AIMD 11-06-2024
  • ATPC 11-14-2024
  • Dividend Yield
  • AIMD N/A
  • ATPC N/A
  • EPS Growth
  • AIMD N/A
  • ATPC N/A
  • EPS
  • AIMD N/A
  • ATPC N/A
  • Revenue
  • AIMD $40,633.00
  • ATPC $1,354,042.00
  • Revenue This Year
  • AIMD N/A
  • ATPC N/A
  • Revenue Next Year
  • AIMD N/A
  • ATPC N/A
  • P/E Ratio
  • AIMD N/A
  • ATPC N/A
  • Revenue Growth
  • AIMD N/A
  • ATPC N/A
  • 52 Week Low
  • AIMD $0.40
  • ATPC $1.36
  • 52 Week High
  • AIMD $4.29
  • ATPC $24.60
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 38.69
  • ATPC 40.67
  • Support Level
  • AIMD $0.44
  • ATPC $1.61
  • Resistance Level
  • AIMD $0.52
  • ATPC $1.53
  • Average True Range (ATR)
  • AIMD 0.05
  • ATPC 0.13
  • MACD
  • AIMD -0.00
  • ATPC -0.01
  • Stochastic Oscillator
  • AIMD 26.90
  • ATPC 7.14

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.

Share on Social Networks: